N-(2-methylquinolin-8-yl)-2-nitro-4-(trifluoromethyl)benzenesulfonamide

ID: ALA269941

PubChem CID: 16759523

Max Phase: Preclinical

Molecular Formula: C17H12F3N3O4S

Molecular Weight: 411.36

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1ccc2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3[N+](=O)[O-])c2n1

Standard InChI:  InChI=1S/C17H12F3N3O4S/c1-10-5-6-11-3-2-4-13(16(11)21-10)22-28(26,27)15-8-7-12(17(18,19)20)9-14(15)23(24)25/h2-9,22H,1H3

Standard InChI Key:  MZDNYCYPYVLIBI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    2.2871    0.1050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2871   -0.7212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9987   -1.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9987    0.5204    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7149    0.1050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7114   -0.7212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4213   -1.1352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1392   -0.7274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4283    0.5174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1402    0.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1537    1.7475    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.4319    1.3416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8656    1.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8525    0.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5568    0.0804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2789    0.4796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2921    1.3050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5831    1.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5557    2.4605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7339    2.4605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5745    0.5142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5941    2.5576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8885    2.9788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3116    2.9581    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9833    0.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9692   -0.7652    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.7019    0.4549    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.6874   -0.3515    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  5  9  2  0
  6  7  2  0
  7  8  1  0
 13 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  8 10  2  0
 11 19  2  0
  9 10  1  0
 11 20  2  0
  3  6  1  0
  1 21  1  0
  5  4  1  0
  5  6  1  0
 22 23  2  0
 22 24  1  0
 18 22  1  0
  9 12  1  0
 16 25  1  0
 13 11  1  0
 25 26  1  0
 11 12  1  0
 25 27  1  0
 13 14  1  0
 25 28  1  0
M  CHG  2  22   1  24  -1
M  END

Alternative Forms

1. Parent:

   

   ALA269941

   N-(2-methylquinolin-8-yl)-2-nitro-4-(trifluoromethyl)benzenesulfonamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 411.36

Molecular Weight (Monoisotopic): 411.0501

AlogP: 4.27

#Rotatable Bonds: 4

Polar Surface Area: 102.20

Molecular Species: ACID

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 5.77

CX Basic pKa: 4.22

CX LogP: 3.41

CX LogD: 2.69

Aromatic Rings: 3

Heavy Atoms: 28

QED Weighted: 0.51

Np Likeness Score: -2.13

References

1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS..  (2008)  Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.,  18  (1): [PMID:18024113] [10.1016/j.bmcl.2007.10.100]

2. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW..  (2009)  The first pharmacophore model for potent NF-kappaB inhibitors.,  19  (19): [PMID:19726185] [10.1016/j.bmcl.2009.08.021]

Source

Source(1):

• Scientific Literature